Coronavirus channel feed

FDA, EU au­thor­i­ties up­date guid­ance on clin­i­cal tri­als dur­ing Covid-19

6 years ago
FDA+

Covid-19 roundup: J&J part­ners with Catal­ent on 1B dose vac­cine goal; BioN­Tech, Pfiz­er be­gin mR­NA vac­cine tri­al in Ger­many

6 years ago

Bank­ing on hope, swayed by hype? Hy­drox­y­chloro­quine in the time of Covid-19

6 years ago
FDA+
In Focus

Covid-19 roundup: Re­searchers claim tri­al suc­cess for Roche's Actem­ra as Alex­ion jumps in; Pfiz­er gam­bling $500M on an am­bi­tious cam­paign

6 years ago

With ex­pan­sive Covid-19 clin­i­cal plan in full gear, Ox­ford team re­ports pos­i­tive an­i­mal da­ta on ade­n­ovirus-based vac­cine

6 years ago

Covid-19 roundup: Sanofi & Re­gen­eron de­liv­er dis­ap­point­ing news on IL-6; Alex Azar ru­mors are swirling at HHS

6 years ago
R&D

Mush­room mag­ic draws $80M in­jec­tion for Lon­don-based men­tal health start­up

6 years ago
Financing
Startups

FDA warns on safe­ty threat posed by 2 drugs ini­tial­ly backed by Trump for Covid-19 — fol­low­ing an emer­gency use au­tho­riza­tion

6 years ago
FDA+

Eli Lil­ly ex­ecs have been think­ing about the longterm ef­fects of the pan­dem­ic and dam­age con­trol. Here’s what they be­lieve

6 years ago
People
R&D

Covid-19 roundup: Sanofi promis­es to bring re­com­bi­nant vac­cine ca­pac­i­ty to 1B+ while scal­ing up mR­NA man­u­fac­tur­ing

6 years ago

FDA al­lows com­pounders to repack­age, com­bine propo­fol amid Covid-19

6 years ago
FDA+

A slice of half-baked remde­sivir da­ta takes a dark turn — but we're still wait­ing for a de­fin­i­tive study

6 years ago
Bioregnum
R&D

Covid-19 roundup: Har­vard sci­en­tist who in­vest­ed in Mod­er­na ear­ly be­comes a pan­dem­ic bil­lion­aire — and he's giv­ing much of the mon­ey away

6 years ago

De­posed BAR­DA chief blasts Trump ad­min­is­tra­tion on pro­mot­ing un­proven drugs as Covid-19 panacea: 'Science — not pol­i­tics or crony­ism — has to lead the way'

6 years ago
People

Covid-19 roundup: Carl June on hav­ing Covid-19 and his plan to treat it; NIH preach­es cau­tion; 2 new vac­cines en­ter clin­ic

6 years ago

BAR­DA chief leaves po­si­tion as agency en­ters un­prece­dent­ed vac­cine cam­paign, rais­ing ques­tions about fed­er­al Covid-19 re­sponse

6 years ago
People

VA study spot­lights high­er death rate among Covid-19 pa­tients treat­ed with the con­tro­ver­sial drug hy­drox­y­chloro­quine

6 years ago
R&D

EMA up­dates on reg­u­la­to­ry ex­pec­ta­tions amid Covid-19

6 years ago
FDA+

Data­vant boots up a big Covid-19 reg­istry — look­ing to shine a light on virus spread, im­pact and most ef­fec­tive ther­a­pies

6 years ago
R&D

Covid-19 roundup: The pan­dem­ic bear — You think a vac­cine and herd im­mu­ni­ty are just months away? Dream on, says biotech an­a­lyst; plus more

6 years ago

Covid-19 roundup: HHS of­fi­cial Giroir takes on role of test­ing czar — cue new con­tro­ver­sy; Wuhan lab ve­he­ment­ly de­nies trig­ger­ing the pan­dem­ic

6 years ago

NIH cor­rals bio­phar­ma com­pa­nies, reg­u­la­tors and tri­al net­works to co­or­di­nate Covid-19 R&D

6 years ago
R&D

Re­port on one PhI­II remde­sivir study sends in­vestors in­to over­drive, adding bil­lions to Gilead­'s mar­ket cap

6 years ago
R&D

Covid-19 roundup: Trump changes tune with plan to lift re­stric­tions; FDA in­di­cates its non-coro­n­avirus pace may take a hit

6 years ago
First page Previous page 52535455565758 Next page Last page
A service from the Financial Times